Login

Suzy Dilly, CEO, ValiRx 00:00:00

Share On Facebook Share On Twitter

Suzy Dilly, ValiRx CEO reiterates her support for TheoremRx and hails 'brilliant science' Cytolytix

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
ACEN CEO Eric Francia provides insights on the renewable energy market in the Philippines.
00:10:00
Michael Saylor, Chairman & CEO of MicroStrategy, Inc., speaks with Bloomberg's Joe Weisenthal at the Bloomberg Crypto Summit about cryptocurrency strategies.
00:10:00
Core Mining: Unlocking Value from Multi-Million Ounce Gold Assets in Safe Jurisdictions
00:10:00
Probability of Making Money in the Stock Market | Ben Smith - FOUNDER & FINANCIAL PLANNER of Cove Financial Planning, LLC
00:10:00
Chairman and CEO Zhang Yichen Discusses China’s Economic Strategy and Growth Focus | Yichen Zhang, CEO , CITIC Capital Holding.
00:10:00
AI in Action: Harvey (Legal) and Grow Therapy (Mental Health) Secure Investment|Pat Grady,partner,Sequoia
00:10:00
Reflecting on a Month of Drastic Changes and Future Investment Strategies | Danny Yong, Chief investment officer, Dymon Asia Capital.
00:10:00
Exploring Potential: Casino Resources' Nickel-Copper Project at One-to-One Mining Conference in London
00:10:00
Securing Six Major Investment Funds, Including a $1 Billion Fund for Company Support|Kirsten Green, founder and Managing Partner, Forerunner Ventures
00:10:00
Venture capital and advisory firm|Hans Morris,Managing Partner,Nyca Partners
00:10:00
Nationwide Commercial Mortgage Solutions with Lasting Client Relationships
00:10:00
Navigating Opportunities in Commercial Real Estate and Private Credit Amidst Negative Sentiment

© 2017 - Neuhu+